LEADER 03662nam  22005175  450 
001 9910158844103321
005 20200701043824.0
010   $a9789812878403
024 7 $a10.1007/978-981-287-840-3
035   $a(CKB)3710000001008959
035   $a(DE-He213)978-981-287-840-3
035   $a(MiAaPQ)EBC4777478
035   $a(PPN)198338910
035   $a(EXLCZ)993710000001008959
100   $a20170105d2017      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDiagnosis and Treatment of Pulmonary Hypertension $eFrom Bench to Bedside /$fedited by Yoshihiro Fukumoto
205   $a1st ed. 2017.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2017.
215   $a1 online resource (VIII, 236 p. 70 illus., 45 illus. in color.) 
311   $a981-287-839-4 
311   $a981-287-840-8 
327   $aPart I Fundamentals of Pulmonary Hypertension -- 1.Clinical Classification -- 2.Diagnosis ? Imagings -- Part II Pathophysiology and Genetics -- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension -- 4.Sex Hormones -- 5.Rho-Kinase -- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension -- 7. Animal Models with Pulmonary Hypertension -- 8.Human Pathology -- 9. Pathophysiology and Genetics: BMPR2 -- Part III Treatment of Pulmonary Arterial Hypertension (PAH) -- 10. Prostacyclin -- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension -- 12. Endothelin Receptor Antagonist -- 13. LUNG TRANSPLANTATION -- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) -- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension -- 15. Balloon Pulmonary Angioplasty -- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension -- Part V Right Ventricular Function -- 17. Right Ventricular Function.
330   $aThis book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH. This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.
606   $aCardiology
606   $aRespiratory organs?Diseases
606   $aCardiac surgery
606   $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037
606   $aPneumology/Respiratory System$3https://scigraph.springernature.com/ontologies/product-market-codes/H33134
606   $aCardiac Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59028
615  0$aCardiology.
615  0$aRespiratory organs?Diseases.
615  0$aCardiac surgery.
615 14$aCardiology.
615 24$aPneumology/Respiratory System.
615 24$aCardiac Surgery.
676   $a616.12
702   $aFukumoto$b Yoshihiro$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910158844103321
996   $aDiagnosis and Treatment of Pulmonary Hypertension$91556197
997   $aUNINA